BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18586062)

  • 1. ELISA underestimates measles antibody seroprevalence in US military recruits.
    Mancuso JD; Krauss MR; Audet S; Beeler JA
    Vaccine; 2008 Sep; 26(38):4877-8. PubMed ID: 18586062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004.
    Eick AA; Hu Z; Wang Z; Nevin RL
    Vaccine; 2008 Jan; 26(4):494-501. PubMed ID: 18155326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Risks for measles and mumps in recruits of the Croatian army].
    Perić D; Gotovac P
    Lijec Vjesn; 2002 Oct; 124(10):301-4. PubMed ID: 12619438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of measles, mumps, and varicella among young adults: a serosurvey of US Navy and Marine Corps recruits.
    Struewing JP; Hyams KC; Tueller JE; Gray GC
    Am J Public Health; 1993 Dec; 83(12):1717-20. PubMed ID: 8259801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The prevalence of measles, rubella, mumps and chickenpox antibodies in a population of health care workers].
    Oliveira J; da Cunha S; Côrte-Real R; Sampaio L; Dais N; Meliço-Silvestre A
    Acta Med Port; 1995 Apr; 8(4):206-16. PubMed ID: 7625214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of plaque reduction neutralisation test (PRNT) and measles virus-specific IgG ELISA for assessing immunogenicity of measles vaccination.
    Cohen BJ; Doblas D; Andrews N
    Vaccine; 2008 Nov; 26(50):6392-7. PubMed ID: 18834911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measles-specific neutralizing antibodies in rural Mozambique: seroprevalence and presence in breast milk.
    Mandomando IM; Naniche D; Pasetti MF; Vallès X; Cuberos L; Nhacolo A; Kotloff KL; Martins H; Levine MM; Alonso P
    Am J Trop Med Hyg; 2008 Nov; 79(5):787-92. PubMed ID: 18981523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rubella, rubeola, and mumps in pregnant women: susceptibilities and strategies for testing and vaccinating.
    Haas DM; Flowers CA; Congdon CL
    Obstet Gynecol; 2005 Aug; 106(2):295-300. PubMed ID: 16055578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The rapid diagnosis of rubella and measles by the dot immunoassay method].
    Arroyave CM
    Bol Med Hosp Infant Mex; 1993 Jun; 50(6):399-405. PubMed ID: 8517935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay.
    Cohen BJ; Parry RP; Doblas D; Samuel D; Warrener L; Andrews N; Brown D
    J Virol Methods; 2006 Feb; 131(2):209-12. PubMed ID: 16188328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of measles antibody in the US population, 1999-2004.
    McQuillan GM; Kruszon-Moran D; Hyde TB; Forghani B; Bellini W; Dayan GH
    J Infect Dis; 2007 Nov; 196(10):1459-64. PubMed ID: 18008224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measles immunity and response to revaccination of a young adult population in Israel.
    Mendelson E; Duvdevani P; Varsano N; Lerman Y; Slepon R; Dagan R; Cohen D; Danon Y; Shohat T
    J Med Virol; 1996 Nov; 50(3):249-53. PubMed ID: 8923290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroprevalence of measles- and rubella-specific antibodies among military recruits, Canada, 1991.
    Duclos P; Tepper ML; Weber J; Marusyk RG
    Can J Public Health; 1994; 85(4):278-81. PubMed ID: 7987753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rubella susceptibility predicts measles susceptibility: implications for postpartum immunization.
    Libman MD; Behr MA; Martel N; Ward BJ
    Clin Infect Dis; 2000 Dec; 31(6):1501-3. PubMed ID: 11096023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination.
    Dine MS; Hutchins SS; Thomas A; Williams I; Bellini WJ; Redd SC
    J Infect Dis; 2004 May; 189 Suppl 1():S123-30. PubMed ID: 15106101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of measles antibody in children of different ages in Shiraz, Islamic Republic of Iran.
    Karimi A; Arjomandi A; Alborzi A; Rasouli M; Kadivar MR; Obood B; Pourabbas B
    East Mediterr Health J; 2004; 10(4-5):468-73. PubMed ID: 16335636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of measles antibody in children.
    Rawat D; Chakravarti A; Yadav S
    Indian Pediatr; 2001 Nov; 38(11):1286-9. PubMed ID: 11721070
    [No Abstract]   [Full Text] [Related]  

  • 20. Measles, Mumps, and Rubella Titers in Air Force Recruits: Below Herd Immunity Thresholds?
    Lewis PE; Burnett DG; Costello AA; Olsen CH; Tchandja JN; Webber BJ
    Am J Prev Med; 2015 Nov; 49(5):757-760. PubMed ID: 26163167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.